Screener
Bausch + Lomb BLCO Surgical — Total revenues
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bausch + Lomb in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Bausch + Lomb’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001860742-26-000088
| (in millions) | Vision Care / Three Months Ended June 30, 2026 | Vision Care / Three Months Ended June 30, 2025 | Pharmaceuticals / Three Months Ended June 30, 2026 | Pharmaceuticals / Three Months Ended June 30, 2025 | Surgical / Three Months Ended June 30, 2026 | Surgical / Three Months Ended June 30, 2025 | Total / Three Months Ended June 30, 2026 | Total / Three Months Ended June 30, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Product Sales | $781 | $751 | $354 | $307 | $254 | $214 | $1,389 | $1,272 |
| Other Revenues | 3 | 2 | — | 2 | 2 | 2 | 5 | 6 |
| 784 | 753 | 354 | 309 | 256 | 216 | 1,394 | 1,278 | |
| Expenses | ||||||||
| Cost of goods sold (excluding amortization and impairments of intangible assets) | 291 | 290 | 89 | 104 | 147 | 129 | ||
| Cost of other revenues | — | — | — | 2 | — | — | ||
| Selling, general and administrative | 247 | 243 | 149 | 154 | 80 | 73 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Bausch + Lomb's surgical — total revenues?
- Bausch + Lomb (BLCO) reported surgical — total revenues of $256M in Q2 2026.
- How has Bausch + Lomb's surgical — total revenues changed year-over-year?
- Bausch + Lomb's surgical — total revenues increased by 18.5% year-over-year, from $216M to $256M.
- What is the long-term trend for Bausch + Lomb's surgical — total revenues?
- Over 4 years (2021 to 2025), Bausch + Lomb's surgical — total revenues has grown at a 5.6% compound annual growth rate (CAGR), from $718M to $894M.
- What does surgical — total revenues mean?
- The total gross income generated from the sale of surgical products, including intraocular lenses and specialized surgical equipment. This is the primary measure of the surgical segment's market demand and top-line performance. Growth in this metric indicates successful product adoption and market penetration within the ophthalmic surgical space.
Ask your AI about Bausch + Lomb's surgical — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude